EPCR-dependent PAR2 activation by the blood coagulation initiation complex regulates LPS-triggered interferon responses in mice.

Blood
Hai Po H LiangHartmut Weiler

Abstract

Infection and inflammation are invariably associated with activation of the blood coagulation mechanism, secondary to the inflammation-induced expression of the coagulation initiator tissue factor (TF) on innate immune cells. By investigating the role of cell-surface receptors for coagulation factors in mouse endotoxemia, we found that the protein C receptor (ProcR; EPCR) was required for the normal in vivo and in vitro induction of lipopolysaccharide (LPS)-regulated gene expression. In cultured bone marrow-derived myeloid cells and in monocytic RAW264.7 cells, the LPS-induced expression of functionally active TF, assembly of the ternary TF-VIIa-Xa initiation complex of blood coagulation, and the EPCR-dependent activation of protease-activated receptor 2 (PAR2) by the ternary TF-VIIa-Xa complex were required for the normal LPS induction of messenger RNAs encoding the TLR3/4 signaling adaptor protein Pellino-1 and the transcription factor interferon regulatory factor 8. In response to in vivo challenge with LPS, mice lacking EPCR or PAR2 failed to fully initiate an interferon-regulated gene expression program that included the Irf8 target genes Lif, Iigp1, Gbp2, Gbp3, and Gbp6. The inflammation-induced expression of TF and cross...Continue Reading

References

Mar 21, 1998·The Journal of Clinical Investigation·G C ParryN Mackman
Nov 22, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·J R LindnerK Ley
May 22, 2003·The American Journal of Pathology·Ryan C FieldsJeffrey H Lawson
Feb 10, 2004·European Journal of Immunology·Heike WeighardtBernhard Holzmann
Mar 9, 2004·Blood Cells, Molecules & Diseases·Saskia H H F SchoenmakersC Arnold Spek
Mar 25, 2004·The Journal of Biological Chemistry·Jasimuddin Ahamed, Wolfram Ruf
Jun 11, 2005·Arteriosclerosis, Thrombosis, and Vascular Biology·Gourab BhattacharjeeThomas S Edgington
Dec 27, 2005·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Yuka KannoKeiko Ozato
Apr 7, 2006·Molecular Immunology·Natalie DrorBen-Zion Levi
Apr 21, 2007·Journal of Thrombosis and Haemostasis : JTH·X ZhengC T Esmon
Aug 1, 2007·Journal of Thrombosis and Haemostasis : JTH·R PawlinskiN Mackman
Aug 7, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Karine TurcottePhilippe Gros
Sep 26, 2007·The Journal of Experimental Medicine·Edward J KerschenHartmut Weiler
Jul 16, 2008·The Journal of Biological Chemistry·Prasad RallabhandiStefanie N Vogel
Feb 27, 2010·Thrombosis Research·Rafal Pawlinski, Nigel Mackman
Apr 15, 2010·The Journal of Biological Chemistry·Katrine S LarsenLars C Petersen
May 7, 2010·Journal of Molecular Modeling·Salvatore Millefiori, Andrea Alparone
Aug 18, 2010·The Journal of Clinical Investigation·Edward KerschenHartmut Weiler
Nov 19, 2010·Molecular Medicine·Alex G CuencaLyle L Moldawer
Apr 29, 2011·The New England Journal of Medicine·Sophie HambletonPhilippe Gros
Jun 15, 2011·The Journal of Clinical Investigation·Christian Furlan-FreguiaWolfram Ruf
Aug 9, 2011·Seminars in Immunopathology·Charles T Esmon
Sep 29, 2011·Journal of Thrombosis and Haemostasis : JTH·J Disse, W Ruf
Nov 26, 2011·Blood·Alexander M de BruinMartijn A Nolte
Dec 12, 2012·Nature Reviews. Immunology·Bernd Engelmann, Steffen Massberg
Mar 8, 2013·Advances in Experimental Medicine and Biology·S Salem, P Gros
Apr 23, 2013·Nature Medicine·Yichuan XiaoShao-Cong Sun
Jul 17, 2013·Journal of Thrombosis and Haemostasis : JTH·E A M BouwensL O Mosnier
Sep 3, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Leah M AlabanzaMargaret S Bynoe
Sep 26, 2013·Frontiers in Cellular and Infection Microbiology·Anuradha RayPrabir Ray
Oct 5, 2013·The Journal of Clinical Investigation·Jeremy D WaightScott I Abrams
Jan 22, 2014·Nature Reviews. Immunology·Paul N Moynagh

❮ Previous
Next ❯

Citations

Mar 2, 2016·Annals of the New York Academy of Sciences·Shiri Gur-CohenTsvee Lapidot
Nov 21, 2015·Blood·Hongmin Sun
Apr 14, 2016·Thrombosis Research·Wolfram RufClaudine Graf
Oct 21, 2016·Memórias do Instituto Oswaldo Cruz·Maria Renata Sales NogueiraMaria Esther Salles Nogueira
Feb 21, 2018·Current Opinion in Hematology·Usha R Pendurthi, L Vijaya Mohan Rao
Jul 22, 2018·Journal of Thrombosis and Haemostasis : JTH·H ZelayaW Ruf
May 26, 2018·Arteriosclerosis, Thrombosis, and Vascular Biology·Wolfram Ruf
Sep 22, 2019·Science Immunology·Claudine GrafWolfram Ruf
Apr 10, 2020·European Journal of Immunology·Lorena Valverde-EstrellaAntonio Celada
Jul 27, 2018·Research and Practice in Thrombosis and Haemostasis·Silvio Antoniak
Apr 4, 2020·Blood·Wolfram Ruf
Jul 27, 2018·Research and Practice in Thrombosis and Haemostasis·Wolfgang BergmeierHartmut Weiler
Jul 16, 2020·Journal of Hematology & Oncology·Dusten Unruh, Craig Horbinski
Mar 13, 2021·Science·Nadine Müller-CallejaWolfram Ruf
Mar 13, 2021·Science·Mariana J Kaplan
Apr 25, 2021·Journal of Thrombosis and Thrombolysis·Wolfram Ruf
Jul 3, 2021·Cancers·Andrew F BerdelTorsten Kessler
Jul 4, 2021·Kidney International·Dario Roccatello, Savino Sciascia
Jul 9, 2021·British Journal of Pharmacology·Saravanan SubramaniamMarkus Bosmann

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Blood Coagulation Signaling Pathways

Coagulation is the process by which a blood clot is formed. This process includes both the formation of a platelet plug as well as a cascade of clotting factors resulting in the formation of fibrin strands. Find the latest research on coagulation signaling pathways here.